Tvardi Therapeutics Inc (TVRD) Wheel Strategy

Running a TVRD wheel strategy lets you generate consistent premium income on Tvardi Therapeutics Inc while setting your own entry and exit prices on the underlying. Tvardi Therapeutics Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own TVRD, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best TVRD wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on TVRD, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable TVRD wheel from a losing one.

Tvardi Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. Their lead candidate, TTI-101, is currently in Phase 2 clinical trials for idiopathic pulmonary fibrosis (IPF) and hepatocellular carcinoma (HCC).

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the TVRD wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your TVRD wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.